NovaBiotics has secured £1.8million in grant funding as part of a Department of Health and Social Care (DHSC) research competition aimed at tackling antimicrobial resistance in humans. The funding is to further develop Novamycin, NovaBiotics' first-in-class antifungal compound which has potential to combat life threatening and drug resistant blood stream and tissue fungal infections. Novamycin is active against fungi, [...]